Clinical importance of serum secreted clusterin in predicting invasive breast cancer and treatment responses
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical importance of serum secreted clusterin in predicting invasive breast cancer and treatment responses
Authors
Keywords
-
Journal
Bioengineered
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2020-12-27
DOI
10.1080/21655979.2020.1868732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Could the glycosylation analysis of seminal plasma clusterin become a novel male infertility biomarker?
- (2020) Ewa Janiszewska et al. MOLECULAR REPRODUCTION AND DEVELOPMENT
- The role of Clusterin in cancer metastasis
- (2019) Mei Peng et al. Cancer Management and Research
- sCLU as prognostic biomarker and therapeutic target in osteosarcoma
- (2019) Jinfeng Ma et al. Bioengineered
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- Expression of Clusterin suppresses Cr(VI)-induced premature senescence through activation of PI3K/AKT pathway
- (2019) Yujing Zhang et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Clinical Features, Prognosis, Diagnostic Approaches and Treatment of Multiple Primary Malignancies in the Digestive System
- (2019) AKASHI IKUBO et al. ANTICANCER RESEARCH
- Prognostic and predictive value of EGFR and EGFR-ligands in blood of breast cancer patients: a systematic review
- (2018) Ina Mathilde Kjaer et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Survivorship care visits in a high-risk population of breast cancer survivors
- (2018) Sarah J. Skuli et al. BREAST CANCER RESEARCH AND TREATMENT
- Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges
- (2018) Casey Burton et al. CURRENT MEDICINAL CHEMISTRY
- Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer
- (2017) Sabina Pucci et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Molecular pathology in real time
- (2016) Aleš Ryška CANCER AND METASTASIS REVIEWS
- The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target
- (2016) T. Tellez et al. CURRENT MEDICINAL CHEMISTRY
- Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer
- (2016) Doireann P. Joyce et al. INTERNATIONAL JOURNAL OF CANCER
- Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury
- (2016) Jia Guo et al. BMC Nephrology
- Diagnostic Importance of Selected Protein Serum Markers in the Primary Diagnostics of Prostate Cancer
- (2015) Otakar Capoun et al. UROLOGIA INTERNATIONALIS
- Downregulating sCLU Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Gemcitabine by Activating the Intrinsic Apoptosis Pathway
- (2014) Peng Xiu et al. DIGESTIVE DISEASES AND SCIENCES
- Breast cancer in China
- (2014) Lei Fan et al. LANCET ONCOLOGY
- Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression
- (2013) Yu Wang et al. JOURNAL OF CHEMOTHERAPY
- Cytoplasmic Clusterin Expression Correlates With Pancreatic Neuroendocrine Tumor Size and Pathological Stage
- (2013) Evita B. Henderson-Jackson et al. PANCREAS
- Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer
- (2012) Z. Niu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Secreted Clusterin in Colon Tumor Cell Models and Its Potentialas Diagnostic Marker for Colorectal Cancer
- (2012) A. M. Rodríguez-Piñeiro et al. CANCER INVESTIGATION
- Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy
- (2011) Allan Lipton et al. CANCER
- Targeting the Cytoprotective Chaperone, Clusterin, for Treatment of Advanced Cancer
- (2010) A. Zoubeidi et al. CLINICAL CANCER RESEARCH
- Overexpression of Clusterin in Ovarian Cancer is Correlated With Impaired Survival
- (2010) Guofen F. Yang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clusterin in Stool: A New Biomarker for Colon Cancer Screening?
- (2009) Sabina Pucci et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prognostic and Predictive Value of HER2 Extracellular Domain in Metastatic Breast Cancer Treated With Lapatinib and Paclitaxel in a Randomized Phase III Study
- (2009) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Clusterin as a Diagnostic and Prognostic Marker for Transitional Cell Carcinoma of the Bladder
- (2009) Sahar M. Hazzaa et al. PATHOLOGY & ONCOLOGY RESEARCH
- Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer
- (2008) Kim N. Chi et al. JOURNAL OF UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started